1. |
Kasturi S, Russell S, Mcvary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep, 2006, 7(4): 288-292.
|
2. |
Dahle SE, Chokkalingam AP, Gao YT, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol, 2002, 168(2): 599-604.
|
3. |
Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol, 2001, 39(2): 151-158.
|
4. |
中國成人血脂異常防治指南制訂聯合委員會, 中國成人血脂異常防治指南. 中華心血管病雜志, 2007, 35: 390-419.
|
5. |
張祥華, 主編. 中國良性前列腺增生診斷治療指南2007版. 人民衛生出版社, 2007: 167-205.
|
6. |
Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007, 51(1): 199-206.
|
7. |
Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab, 2006, 91(7): 2562-2568.
|
8. |
Gupta A, Gupta S, Pavuk M, et al. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of air force veterans. Urology, 2006, 68(6): 1198-1205.
|
9. |
Park HK, Lee HW, Lee KS, et al. Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population. Urology, 2008, 72(3): 556-560.
|
10. |
Temml C, Obermayr R, Marszalek M, et al. Are lower urinary tract symptoms influenced by metabolic syndrome? Urology, 2009, 73(3): 544-548.
|